NT5C1B
gene geneOn this page
Also known as AIRPCN-IB
Summary
NT5C1B (5’-nucleotidase, cytosolic IB, HGNC:17818) is a protein-coding gene on chromosome 2p24.2, encoding Cytosolic 5’-nucleotidase 1B (Q96P26). Catalyzes the hydrolysis of nucleotide monophosphates, releasing inorganic phosphate and the corresponding nucleoside, AMP is the major substrate.
Cytosolic 5-prime nucleotidases, such as NT5C1B, catalyze production of adenosine, which regulates diverse physiologic processes (Sala-Newby and Newby, 2001 [PubMed 11690631]).
Source: NCBI Gene 93034 — RefSeq curated summary.
At a glance
- GWAS associations: 18
- Clinical variants (ClinVar): 109 total
- MANE Select transcript:
NM_033253
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17818 |
| Approved symbol | NT5C1B |
| Name | 5’-nucleotidase, cytosolic IB |
| Location | 2p24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | AIRP, CN-IB |
| Ensembl gene | ENSG00000185013 |
| Ensembl biotype | protein_coding |
| OMIM | 610526 |
| Entrez | 93034 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 4 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000304081, ENST00000359846, ENST00000406971, ENST00000416783, ENST00000418427, ENST00000460052, ENST00000490687
RefSeq mRNA: 5 — MANE Select: NM_033253
NM_001002006, NM_001199086, NM_001199087, NM_001199088, NM_033253
CCDS: CCDS33149, CCDS33150
Canonical transcript exons
ENST00000304081 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001945896 | 18589439 | 18589569 |
| ENSE00003467468 | 18587503 | 18587592 |
| ENSE00003533496 | 18582868 | 18582997 |
| ENSE00003560288 | 18584088 | 18584255 |
| ENSE00003566800 | 18576184 | 18576368 |
| ENSE00003677436 | 18584514 | 18584978 |
| ENSE00003682687 | 18576773 | 18576895 |
| ENSE00003687955 | 18586254 | 18586391 |
| ENSE00003978121 | 18562871 | 18564119 |
Expression profiles
Bgee: expression breadth ubiquitous, 157 present calls, max score 99.56.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0088 / max 7.2174, expressed in 3 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 27050 | 0.0887 | 3 |
| 27049 | 0.0088 | 3 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 99.56 | gold quality |
| left testis | UBERON:0004533 | 91.03 | gold quality |
| right testis | UBERON:0004534 | 90.83 | gold quality |
| testis | UBERON:0000473 | 88.34 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.06 | gold quality |
| adult organism | UBERON:0007023 | 82.64 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 74.01 | gold quality |
| tibialis anterior | UBERON:0001385 | 71.51 | silver quality |
| pancreatic ductal cell | CL:0002079 | 69.52 | silver quality |
| right coronary artery | UBERON:0001625 | 68.34 | gold quality |
| right lobe of liver | UBERON:0001114 | 67.83 | gold quality |
| lower esophagus | UBERON:0013473 | 67.60 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 67.54 | gold quality |
| islet of Langerhans | UBERON:0000006 | 67.11 | gold quality |
| ileal mucosa | UBERON:0000331 | 66.22 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 66.22 | gold quality |
| esophagus | UBERON:0001043 | 65.37 | gold quality |
| rectum | UBERON:0001052 | 65.33 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 64.34 | gold quality |
| esophagus mucosa | UBERON:0002469 | 63.60 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 63.56 | gold quality |
| body of stomach | UBERON:0001161 | 63.44 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 62.73 | gold quality |
| apex of heart | UBERON:0002098 | 62.49 | gold quality |
| stomach | UBERON:0000945 | 62.10 | gold quality |
| thoracic aorta | UBERON:0001515 | 61.94 | gold quality |
| ascending aorta | UBERON:0001496 | 61.88 | gold quality |
| skin of abdomen | UBERON:0001416 | 61.87 | gold quality |
| tibial artery | UBERON:0007610 | 61.87 | gold quality |
| popliteal artery | UBERON:0002250 | 61.81 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.81 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
31 targeting NT5C1B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-5580-3P | 99.70 | 69.41 | 2052 |
| HSA-MIR-587 | 99.64 | 70.86 | 2611 |
| HSA-MIR-5197-5P | 99.64 | 69.08 | 1494 |
| HSA-MIR-4756-3P | 99.62 | 66.30 | 1319 |
| HSA-MIR-12122 | 99.56 | 69.33 | 1672 |
| HSA-MIR-1252-3P | 99.55 | 67.71 | 2862 |
| HSA-MIR-3616-5P | 99.55 | 67.02 | 989 |
| HSA-MIR-573 | 99.55 | 67.44 | 955 |
| HSA-MIR-4672 | 99.50 | 71.58 | 2893 |
| HSA-MIR-4519 | 99.48 | 66.10 | 859 |
| HSA-MIR-653-5P | 99.46 | 67.35 | 1300 |
| HSA-MIR-4652-3P | 99.33 | 70.02 | 2742 |
| HSA-MIR-122B-3P | 99.21 | 68.90 | 1333 |
| HSA-MIR-21-3P | 99.21 | 68.95 | 1312 |
| HSA-MIR-4795-5P | 99.11 | 66.90 | 876 |
| HSA-MIR-421 | 98.90 | 67.04 | 1883 |
| HSA-MIR-4764-5P | 98.88 | 65.53 | 894 |
| HSA-MIR-3161 | 98.71 | 67.14 | 816 |
| HSA-MIR-4274 | 98.59 | 66.10 | 630 |
| HSA-MIR-548AO-5P | 98.55 | 69.57 | 1362 |
| HSA-MIR-548AX | 98.55 | 69.58 | 1362 |
| HSA-MIR-4709-5P | 98.51 | 67.25 | 1335 |
| HSA-MIR-7114-5P | 98.51 | 67.87 | 1349 |
| HSA-MIR-1182 | 96.41 | 64.89 | 336 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nt5c1ba | ENSDARG00000018153 |
| danio_rerio | nt5c1bb | ENSDARG00000033742 |
| mus_musculus | Nt5c1b | ENSMUSG00000020622 |
| rattus_norvegicus | Nt5c1b | ENSRNOG00000004296 |
Paralogs (1): NT5C1A (ENSG00000116981)
Protein
Protein identifiers
Cytosolic 5’-nucleotidase 1B — Q96P26 (reviewed: Q96P26)
Alternative names: Autoimmune infertility-related protein, Cytosolic 5’-nucleotidase IB
All UniProt accessions (5): Q96P26, A0A140VJC7, C4AM88, C9JW75, H7BZQ4
UniProt curated annotations — full annotation on UniProt →
Function. Catalyzes the hydrolysis of nucleotide monophosphates, releasing inorganic phosphate and the corresponding nucleoside, AMP is the major substrate.
Subcellular location. Cytoplasm.
Tissue specificity. Highly expressed in testis, placenta and pancreas. Detected at lower levels in heart, kidney, liver and lung.
Activity regulation. Activated by ADP.
Similarity. Belongs to the 5’-nucleotidase type 3 family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96P26-1 | 1, CN-Ib alpha | yes |
| Q96P26-2 | 2 | |
| Q96P26-3 | 3 | |
| Q96P26-4 | 4 |
RefSeq proteins (5): NP_001002006, NP_001186015, NP_001186016, NP_001186017, NP_150278* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010394 | 5-nucleotidase | Family |
Pfam: PF06189
Catalyzed reactions (Rhea), 2 shown:
- a ribonucleoside 5’-phosphate + H2O = a ribonucleoside + phosphate (RHEA:12484)
- AMP + H2O = adenosine + phosphate (RHEA:29375)
UniProt features (19 total): sequence conflict 7, compositionally biased region 5, splice variant 3, region of interest 2, chain 1, active site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96P26-F1 | 63.86 | 0.31 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 467 (nucleophile)
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-74259 | Purine catabolism |
| R-HSA-1430728 | Metabolism |
| R-HSA-15869 | Metabolism of nucleotides |
| R-HSA-8956319 | Nucleotide catabolism |
MSigDB gene sets: 59 (showing top):
GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS, GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS, BRN2_01, GOBP_ORGANOPHOSPHATE_CATABOLIC_PROCESS, TGANTCA_AP1_C, TGACATY_UNKNOWN, KEGG_PURINE_METABOLISM, GOBP_NUCLEOSIDE_PHOSPHATE_CATABOLIC_PROCESS, AFFAR_YY1_TARGETS_DN, GOBP_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOBP_PURINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS, FOX_Q2, EVI1_04, GOMF_MAGNESIUM_ION_BINDING
GO Biological Process (3): purine nucleotide catabolic process (GO:0006195), adenosine metabolic process (GO:0046085), nucleotide metabolic process (GO:0009117)
GO Molecular Function (4): nucleotide binding (GO:0000166), magnesium ion binding (GO:0000287), 5’-nucleotidase activity (GO:0008253), hydrolase activity (GO:0016787)
GO Cellular Component (3): nucleus (GO:0005634), cytosol (GO:0005829), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Nucleotide catabolism | 1 |
| Metabolism | 1 |
| Metabolism of nucleotides | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| purine nucleotide metabolic process | 1 |
| nucleotide catabolic process | 1 |
| purine-containing compound catabolic process | 1 |
| purine ribonucleoside metabolic process | 1 |
| nucleoside phosphate metabolic process | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| metal ion binding | 1 |
| nucleotidase activity | 1 |
| catalytic activity | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
1741 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NT5C1B | NT5M | Q9NPB1 | 627 |
| NT5C1B | NT5C3B | Q969T7 | 599 |
| NT5C1B | NT5C | Q8TCD5 | 598 |
| NT5C1B | NT5C2 | P49902 | 523 |
| NT5C1B | TMEM202 | A6NGA9 | 516 |
| NT5C1B | LKAAEAR1 | Q8TD35 | 506 |
| NT5C1B | NT5C3A | Q9H0P0 | 492 |
| NT5C1B | EFCAB10 | A6NFE3 | 471 |
| NT5C1B | NME6 | O75414 | 461 |
| NT5C1B | SPEM3 | A0A1B0GUW6 | 448 |
| NT5C1B | SPATA31F1 | Q6ZU69 | 447 |
| NT5C1B | C4orf17 | Q53FE4 | 433 |
| NT5C1B | DUXB | A0A1W2PPF3 | 425 |
| NT5C1B | PRR30 | Q53SZ7 | 421 |
| NT5C1B | GARIN3 | Q8TC56 | 419 |
IntAct
0 interactions, top by confidence:
BioGRID (4): NT5C1B (Affinity Capture-MS), NT5C1B (Affinity Capture-MS), NT5C1B (Cross-Linking-MS (XL-MS)), NT5C1B (Reconstituted Complex)
ESM2 similar proteins: A0A2R8VHF7, A0JM23, A2QRA0, A4IIA7, A4IIV4, A6NFN9, A6NHR9, A7MBF6, F4IG73, F4JSE7, O17482, O95876, P12540, P21784, P34089, P38899, P55895, P56696, Q08AW4, Q0D2D7, Q12789, Q13829, Q28DC9, Q2WGJ8, Q3E7Y5, Q3UUE9, Q4R907, Q4VXA5, Q5BK83, Q5EA90, Q5F476, Q5HZS2, Q5M9F0, Q5RAX4, Q5RBH4, Q5RD21, Q6AYL6, Q6DGA7, Q6PIY5, Q70XZ2
Diamond homologs: A3KFX0, Q91YE9, Q96P26, Q9BXI3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
109 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 100 |
| Likely benign | 6 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1519 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:18584082:GAATA:G | donor_loss | 1.0000 |
| 2:18584083:AATAC:A | donor_loss | 1.0000 |
| 2:18584084:ATAC:A | donor_loss | 1.0000 |
| 2:18584085:TAC:T | donor_loss | 1.0000 |
| 2:18584087:C:A | donor_loss | 1.0000 |
| 2:18587594:T:C | acceptor_gain | 1.0000 |
| 2:18576179:CCTA:C | donor_loss | 0.9900 |
| 2:18576180:CTA:C | donor_loss | 0.9900 |
| 2:18576181:TA:T | donor_loss | 0.9900 |
| 2:18576182:A:C | donor_loss | 0.9900 |
| 2:18576183:C:G | donor_loss | 0.9900 |
| 2:18576199:A:AC | donor_gain | 0.9900 |
| 2:18576200:C:CC | donor_gain | 0.9900 |
| 2:18576202:TTC:T | donor_gain | 0.9900 |
| 2:18576219:A:AC | donor_gain | 0.9900 |
| 2:18576220:C:CC | donor_gain | 0.9900 |
| 2:18576366:TAC:T | acceptor_gain | 0.9900 |
| 2:18576366:TACCT:T | acceptor_loss | 0.9900 |
| 2:18576367:ACCT:A | acceptor_loss | 0.9900 |
| 2:18576368:CCT:C | acceptor_loss | 0.9900 |
| 2:18576369:C:A | acceptor_loss | 0.9900 |
| 2:18576370:T:G | acceptor_loss | 0.9900 |
| 2:18576372:A:C | acceptor_gain | 0.9900 |
| 2:18576775:T:A | donor_gain | 0.9900 |
| 2:18582862:ACTT:A | donor_loss | 0.9900 |
| 2:18582863:CTTA:C | donor_loss | 0.9900 |
| 2:18582864:TTAC:T | donor_loss | 0.9900 |
| 2:18582865:TACC:T | donor_loss | 0.9900 |
| 2:18582866:ACCGT:A | donor_loss | 0.9900 |
| 2:18582867:C:CT | donor_loss | 0.9900 |
AlphaMissense
3587 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:18563966:A:G | W555R | 0.994 |
| 2:18563966:A:T | W555R | 0.994 |
| 2:18582881:G:C | S396R | 0.987 |
| 2:18582881:G:T | S396R | 0.987 |
| 2:18582883:T:G | S396R | 0.987 |
| 2:18563937:G:C | F564L | 0.986 |
| 2:18563937:G:T | F564L | 0.986 |
| 2:18563939:A:G | F564L | 0.986 |
| 2:18564069:G:C | F520L | 0.986 |
| 2:18564069:G:T | F520L | 0.986 |
| 2:18564071:A:G | F520L | 0.986 |
| 2:18576299:G:T | A465D | 0.982 |
| 2:18584205:G:C | F318L | 0.981 |
| 2:18584205:G:T | F318L | 0.981 |
| 2:18584207:A:G | F318L | 0.981 |
| 2:18563974:A:G | L552P | 0.980 |
| 2:18563974:A:T | L552H | 0.980 |
| 2:18564025:A:G | L535P | 0.980 |
| 2:18563893:G:T | P579H | 0.979 |
| 2:18563964:C:A | W555C | 0.979 |
| 2:18563964:C:G | W555C | 0.979 |
| 2:18576296:A:G | F466S | 0.979 |
| 2:18563938:A:G | F564S | 0.978 |
| 2:18564029:A:C | Y534D | 0.978 |
| 2:18576295:A:C | F466L | 0.976 |
| 2:18576295:A:T | F466L | 0.976 |
| 2:18576297:A:G | F466L | 0.976 |
| 2:18564078:T:A | Q517H | 0.974 |
| 2:18564078:T:G | Q517H | 0.974 |
| 2:18563983:A:G | L549P | 0.973 |
dbSNP variants (sampled 300 via entrez): RS1000006558 (2:18570024 G>A), RS1000043575 (2:18581243 A>G), RS1000108601 (2:18562599 G>A), RS1000203703 (2:18587249 TC>T,TCC,TCCC), RS1000247039 (2:18588162 A>G,T), RS1000602565 (2:18579642 A>G), RS1000856533 (2:18577697 A>G), RS1000956543 (2:18585926 TC>T), RS1001343705 (2:18563535 A>G,T), RS1001428896 (2:18583725 G>A), RS1001608798 (2:18588398 A>G), RS1001638934 (2:18583162 T>C), RS1001708307 (2:18588710 G>A), RS1001763612 (2:18589044 G>A,T), RS1002099141 (2:18590625 G>T)
Disease associations
OMIM: gene MIM:610526 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
18 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001958_19 | Bulimia nervosa | 1.000000e-07 |
| GCST003991_8 | Childhood ear infection | 2.000000e-10 |
| GCST004031_6 | QT interval (sulfonylurea treatment interaction) | 8.000000e-08 |
| GCST006479_142 | Diverticular disease | 4.000000e-08 |
| GCST006624_64 | Systolic blood pressure | 2.000000e-12 |
| GCST007344_14 | Estimated glomerular filtration rate | 1.000000e-08 |
| GCST008747_67 | Estimated glomerular filtration rate | 4.000000e-13 |
| GCST009723_91 | Vertical cup-disc ratio (adjusted for vertical disc diameter) | 3.000000e-06 |
| GCST009723_99 | Vertical cup-disc ratio (adjusted for vertical disc diameter) | 3.000000e-06 |
| GCST009724_90 | Vertical cup-disc ratio (multi-trait analysis) | 1.000000e-09 |
| GCST009724_91 | Vertical cup-disc ratio (multi-trait analysis) | 8.000000e-09 |
| GCST010697_8 | Cortical surface area (min-P) | 9.000000e-11 |
| GCST010698_76 | Subcortical volume (min-P) | 6.000000e-13 |
| GCST010699_22 | Brain morphology (min-P) | 9.000000e-10 |
| GCST010700_49 | Cortical thickness (MOSTest) | 2.000000e-10 |
| GCST010701_21 | Cortical surface area (MOSTest) | 1.000000e-76 |
| GCST010702_13 | Subcortical volume (MOSTest) | 4.000000e-08 |
| GCST010703_331 | Brain morphology (MOSTest) | 2.000000e-10 |
EFO canonical traits (8, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007904 | susceptibility to childhood ear infection measurement |
| EFO:0004682 | QT interval |
| EFO:0007922 | response to sulfonylurea |
| EFO:0009959 | diverticular disease |
| EFO:0006335 | systolic blood pressure |
| EFO:0006939 | cup-to-disc ratio measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004840 | cortical thickness |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: enzyme — Adenosine turnover
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): bulimia nervosa